We have located links that may give you full text access.
Complicated urinary tract infections.
American Journal of Medicine 1985 August 10
The distinction between complicated and uncomplicated urinary tract infections is usually based on the presence or absence of some abnormality in the path of urine flow. Other differences include characteristic patient profiles, usual setting, likely pathogens and their antimicrobial susceptibility, and treatment options. Complicated infections are most common in older patients, usually men with prostatic enlargement. Gram-negative bacilli are the most frequent pathogens, but Escherichia coli plays a less dominant role. Isolates from patients with complicated infections are more likely to be resistant to older antibiotics, and therapy is usually parenteral. Many complicated urinary tract infections are hospital-acquired, and are often due to indwelling urinary catheters. Resistance to antimicrobials among isolates is common in this setting. Nosocomial urinary tract infections contribute substantially to morbidity, mortality, and health care costs. Numerous effective treatment options are available for uncomplicated infections. The types of patients, predisposing factors, and organisms limit antimicrobial choices for complicated infections. Although new antibiotics offer certain advantages, final therapeutic success usually depends on resolving the disorder that predisposes the patient to infection.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app